期刊文献+

SERUM CONCENTRATIONS OF HYALURONIC ACID, PROCOLLAGEN TYPE III NH_2-TERMINAL PEPTIDE, AND LAMININ IN PATIENTS WITH CHRONIC CONGESTIVE HEART FAILURE 被引量:14

SERUM CONCENTRATIONS OF HYALURONIC ACID, PROCOLLAGEN TYPE III NH_2-TERMINAL PEPTIDE, AND LAMININ IN PATIENTS WITH CHRONIC CONGESTIVE HEART FAILURE
暂未订购
导出
摘要 Objective To explore the role of serum fibrotic indices including hyaluronic acid (HA), procollagen type Ⅲ NH2-terminal peptide (PCIIIP), and laminin (LN) in assessing the severity of myocardial fibrosis in chronic congestive heart failure (CHF). Methods Serum levels of HA, PCIIIP, and LN in 39 patients with CHF E [14 with New York Heart Association (NYHA) functional class II, 21 with class Ⅲ, 4 with class Ⅳ] and in 46 patients with NYHA functional class I were assessed by radioimmunoassay. Results The serum concentrations of HA, PCMP, and LN were 359.75 ± 84.59 μg/L, 77.88 ± 24. 67 μg/L, 86. 73 ± 23.90 μg/L in CHF group, and 211.60 ±54. 80 μg/L, 64.82 ±23.99 μg/L, 82. 26 ±23.98 μg/L in NYHA functional class Ⅰ group, respectively. The HA level was significantly higher in CHF patients as compared with NYHA functional class Ⅰ group ( P 〈 0.05 ). However, no difference was found in the levels of PCIIIP and LN between CHF group and NYHA functional class Ⅰ group. The serum HA concentration was negatively correlated with left ventricular ejection fraction ( r = - 0.71, P 〈 0.05 ). Conclusion Serum HA level may act as an indicator for myocardial fibrosis.
出处 《Chinese Medical Sciences Journal》 CAS CSCD 2006年第3期175-178,共4页 中国医学科学杂志(英文版)
关键词 congestive heart failure hyaluronic acid procollagen type NH2-terminal peptide LAMININ 浓聚物 血清 胶原蛋白 缩氨酸 慢性充血性心力衰竭
  • 相关文献

参考文献14

  • 1[1]Banff C,Cavalca V,Veglia F,et al.Neurohormonal activation is associated with increased levels of plasma matrix metalloproteinase-2 in human heart failure.Eur Heart J 2005;26:481-8.
  • 2[2]Reinhardt D,Sigusch HH,Hensse J,et al.Cardiac remodelling in end stage heart failure:upregulation of matrix metalloproteinase(MMP)irrespective of the underlying disease,and evidence for a direct inhibitory effect of ACE inhibitors on MMP.Heart2002;88:525-30.
  • 3[3]Yamazaki T,Lee JD,Shimizu H,et al.Circulating matrix metalloproteinase-2 is elevated in patients with congestive heart failure.Eur J Heart Fail 2004;6:41-5.
  • 4[4]Wilson EM,Gunasinghe HR,Coker ML,et al.Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure.J Card Fail 2002;8:390-8.
  • 5[5]Spinale FG,Coker ML,Heung LJ,et al.A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure.Circulation 2000;102:1944-9.
  • 6[6]Wilke A,Funck R,Rupp H,et al.Effect of the renin-angiotensin-aldosterone system on the cardiac interstitium in heart failure.Basic Res Cardiol 1996;91 Suppl 2:79-84.
  • 7[7]Brilla CG,Rupp H,Funck R,et al.The renin-angiotensin-aldosterone system and myocardial collagen matrix remodelling in congestive heart failure.Eur Heart J 1995;16 Suppl O:107-9.
  • 8[8]Weber KT.Extracellular matrix remodeling in heart failure:a role for de novo angiotensin Ⅱ generation.Circulation 1997;96:4065-82.
  • 9[9]Lijnen P,Petrov V.Induction of cardiac fibrosis by aldosterone.J Mol Cell Cardiol 2000;32:865-79.
  • 10[10]Beggah AT,Escoubet B,Puttini S,et al.From the cover:reversible cardiac fibrosis and heart failure induced by conditional expression of an antisense mRNA of the mineralocorticoid receptor in cardiomyocytes.Proc Nat Acad Sci U S A 2002;99:7160-5.

同被引文献92

引证文献14

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部